Total Utang marang Modal Atrion (ATRI)

Atrion Corporation (ATRI) - logo korporat

Atrion Corporation (ATRI) protects its market position through patent purity and strict FDA regulations, making it difficult for clients to switch suppliers. Business development is based on strategic alliances with ophthalmology and cardiology centers. This chart of the share price on GURU.Markets shows that the indicator is 0.00, supporting the company's focus on creating precision fluid delivery systems for oncology and surgery.

ATRI: Rasio Utang marang Ekuitas atrioncorp.com 04.07.2022 - 31.08.2024

Rincian analitis perusahaan Atrion Corporation

- rega lan prakiraan konsensus rega:
Bagan rega Atrion|ATRI - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Atrion|ATRI - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Atrion|ATRI - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku atrioncorp.com|ATRI - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Atrion Corporation|ATRI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Atrion Corporation|ATRI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Atrion|ATRI - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Atrion|Rasio cepet atrioncorp.com
- informasi bathi lan kelipatan valuasi:
ATRI - Asil keuangan resik
Analisis dhasar perusahaan:ATRI, Atrion
Produk dadi Atrion Corporation Inc.

This metric measures the proportion of debt relative to equity, allowing investors to filter out market volatility and assess the real financial stability of the business by analyzing the balance between borrowed and equity capital. Monitoring leverage is critically important for Atrion Corporation (ATRI), as the high margins of serial production for unique medical components require optimal leverage to scale automated manufacturing facilities without the risk of bankruptcy.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal zimvie.com ZIMV|AngioDynamics (ANGO) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CERS|Utang marang Ekuitas Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas STSS (Sharps Technology, Inc.)|Utang Agregat marang Modal INFU|Utang marang Ekuitas Utah Medical Products, Inc. UTMD|Rasio Kabeh Utang marang Dana Pribadi KRMD|NYXH: Rasio Total Utang marang Ekuitas|MBOT - Total Utang marang Modal|Pro-Dex, Inc. (PDEX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas zentek.com|ELUT (Elutia) - Total Utang marang Modal|Utang marang Modal Milestone Scientific Inc MLSS|Utang marang Ekuitas NEXGEL, Inc (NXGL)|retractable.com - Rasio Utang marang Ekuitas|Harvard Bioscience, Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal FEMY (femasys.com)|MHUA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Predictive Oncology POAI|CJMB: Total Utang marang Modal|NeuroMetrix Corporation (NURO) - Total Utang marang Modal